Temporal kinetics of antibody and cellular response markers and relative impact of revaccination in patients recovered from COVID-19 after treatment with monoclonal antibodies
Latest Information Update: 14 Jun 2022
At a glance
- Drugs Cilgavimab/tixagevimab (Primary) ; COVID-19 vaccine adjuvanted Novavax (Primary) ; Elasomeran (Primary) ; Sotrovimab (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms RENOIR
Most Recent Events
- 14 Jun 2022 New trial record